Andrew L. Pecora, MD

Articles

Dr. Pecora on the Role of Stem Cell Transplant in Patients With Multiple Myeloma

June 23rd 2018

Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, discusses the role of stem cell transplant in patients with multiple myeloma.

Dr. Pecora on the Significant Results of CTLA-4 and PD-1 Combination in Multiple Myeloma

January 23rd 2018

Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, discusses the results of a trial investigating the combination of CTLA-4 and PD-1 inhibitors for patients with multiple myeloma.

Dr. Pecora on CTLA-4 and PD-1 Combinations in Multiple Myeloma

January 3rd 2018

Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, discusses the combination of CTLA-4 and PD-1 inhibitors for the treatment of patients with multiple myeloma.

Hospital Cost Comparisons Should Be Fair

December 31st 2017

The debate continues to rage over whether the difference in the cost of oncologic care between outpatient hospital and physician private offices is appropriate.

Dr. Pecora on the CPIT001 Study in Hematologic Malignancies

December 16th 2017

Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, discusses the CPIT001 study for patients with hematologic malignancies.

Doing No Harm Starts With Good Hazardous Drug Management

November 25th 2017

Oncologists in private offices who supply chemotherapy and biologic infusion therapies for their patients have until recently been exempt from regulations that protect the workplace from aerosolized contaminating agents.

The Quirky Way Physicians Are Paid

October 29th 2017

In community oncology, the complexity and cost of therapy and therapy administration have caused the cost of delivering a service to rise disproportionately relative to actual payment.

What If You Cannot Afford CAR T-Cells?

August 26th 2017

Despite all the excitement and anticipation, there is a growing anxiety among payers and providers regarding the cost of CAR T cells.

Not All Care Pathways Lead to Optimal Outcomes and Cost

August 5th 2017

To optimize clinical outcomes and reduce the total cost of care, it is important to limit physicians’ choices of care.

MedPAC's Drug Price Solution May Be a Problem in Disguise

July 4th 2017

Over the past 3 years, there has been a growing chorus of complaint about the rising costs of medications, particularly in oncology.

Is Healthcare Ready for an Uber-Type Patient Application?

June 10th 2017

Genomics, proteomics, precision analytics, Big Data analysis, and artificial intelligence now in use or in late phases of development can help healthcare providers to achieve the promises of the Triple Aim of medicine: improve clinical outcomes for all, reduce total cost of care for the populations served, and improve patient experiences

Science Marches On and Policy Lags Behind

May 7th 2017

The research presented at AACR focused on the fundamentals of cell biology, cell aging, and cell death; how the immune system recognizes and kills cancer cells; and how, in turn, cancer cells avoid immune system detection.

Solve Big Questions by Joining Forces

April 13th 2017

To get physicians to work together, an organizing structure is needed and the drive to create partnerships.

Share the Responsibility or Share the Suffering

February 23rd 2017

Andrew L. Pecora, MD, discusses his hopes for healthcare reform if the the Affordable Care Act is repealed.

Bundles Offer Better Outcomes and Savings

February 15th 2017

The primary goal of a cancer diagnosis is to end up with the best possible outcome, and there are always several highways of care, or bundles, to choose from.

T Cells Move Into the Fast Lane

January 14th 2017

Over the past 30 years, I have regularly attended annual meetings of the American Society of Hematology, where experts from around the globe convene to share the latest advances.

Immuno-Oncology: The Straw That Breaks the Payer's Back?

December 24th 2016

It is almost unimaginable. Oncologists have waited for decades to offer their patients a better chance of surviving cancer, and now they can—for multiple cancer types.

Chasing Value Through an Imperfect Lens

November 25th 2016

We all know that healthcare is at a crossroads: to the left, there is rationed care, and to the right, you have economic insolvency, if we remain on our current course.

Throw a House Instead of a Marble

September 24th 2016

As the cost comes down due to new technologies and as studies mature, maybe the value equation for common malignancies will favor proton beam therapy. However, it is hard to imagine how throwing a house will ever be as cost-efficient as throwing a marble.

Dr. Pecora on Oncology Care Model Innovations

August 19th 2016

Andrew L. Pecora, MD, president of the Physician Services Division and chief innovation officer at Hackensack Meridian Health, discusses the Oncology Care Model (OCM) and other aspects of healthcare reform.